Dashboard
Manage Tickers

ARTL


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-artelo-biosciences-maintains-5-price-target
HC Wainwright & Co. Reiterates Buy on Arte...
08/14/2024 12:10:36

HC Wainwright & Co. analyst Vernon Bernardino reiterates Artelo Biosciences (NASDAQ:ARTL) with a Buy and maintains $5 pr...

artelo-biosciences-q2-eps-075-beats-085-estimate
Artelo Biosciences Q2 EPS $(0.75) Beats $(...
08/13/2024 12:19:28

Artelo Biosciences (NASDAQ:ARTL) reported quarterly losses of $(0.75) per share which beat the analyst consensus estimate of $(...

Core News & Articles
Market-Moving News for July 15th
07/15/2024 12:38:19

DJT: 75% | Trump Media & Technology Group shares are trading higher following the attempted assassination of Donald Trump. ...

artelo-biosciences-receives-fda-clearance-of-its-ind-application-for-art2612
Artelo Biosciences Receives FDA Clearance ...
07/15/2024 12:32:11

artelo-biosciences-presents-data-from-preclinical-studies-on-art1211-at-34th-annual-international-cannabinoid-research-society-symposium
Artelo Biosciences Presents Data From Prec...
07/03/2024 13:02:09

artelo-biosciences-presents-preclinical-data-on-art2612-for-breast-cancer-induced-bone-pain-at-34th-annual-international-cannabinoid-research-society-symposium
Artelo Biosciences Presents Preclinical Da...
07/01/2024 13:05:40

hc-wainwright--co-reiterates-buy-on-artelo-biosciences-maintains-5-price-target
HC Wainwright & Co. Reiterates Buy on Arte...
06/05/2024 10:47:49

HC Wainwright & Co. analyst Vernon Bernardino reiterates Artelo Biosciences (NASDAQ:ARTL) with a Buy and maintains $5 pr...

artelo-biosciences-announces-presentation-of-new-preclinical-data-on-art2612-by-professor-saoirse-osullivan-at-british-pain-society-annual-meeting
Artelo Biosciences Announces Presentation ...
06/04/2024 12:31:51

artelo-biosciences-reports-data-for-developing-solid-dosage-form-of-art1211-at-ct-cann24
Artelo Biosciences Reports Data For Develo...
05/29/2024 12:31:42

hc-wainwright--co-reiterates-buy-on-artelo-biosciences-maintains-5-price-target
HC Wainwright & Co. Reiterates Buy on Arte...
05/15/2024 11:16:58

HC Wainwright & Co. analyst Vernon Bernardino reiterates Artelo Biosciences (NASDAQ:ARTL) with a Buy and maintains $5 pr...

artelo-biosciences-q1-eps-078-beats-105-estimate
Artelo Biosciences Q1 EPS $(0.78) Beats $(...
05/13/2024 12:18:35

Artelo Biosciences (NASDAQ:ARTL) reported quarterly losses of $(0.78) per share which beat the analyst consensus estimate of $(...

artelo-biosciences-reports-publication-peer-reviewed-article-titled-the-emerging-role-of-fatty-acid-binding-protein-7-fabp7-in-cancers
Artelo Biosciences Reports Publication Pee...
04/23/2024 12:37:37

hc-wainwright--co-maintains-buy-on-artelo-biosciences-maintains-5-price-target
HC Wainwright & Co. Maintains Buy on Artel...
04/02/2024 15:42:00

HC Wainwright & Co. analyst Vernon Bernardino maintains Artelo Biosciences (NASDAQ:ARTL) with a Buy and maintains $5 pri...

artelo-biosciences-earlier-reported-q4-eps-099-misses-056-estimate
Artelo Biosciences Earlier Reported Q4 EPS...
03/25/2024 20:29:14

Artelo Biosciences (NASDAQ:ARTL) reported quarterly losses of $(0.99) per share which missed the analyst consensus estimate of ...

recap-artelo-biosciences-q4-earnings
Recap: Artelo Biosciences Q4 Earnings
03/25/2024 13:20:07

artelo-biosciences-fy23-eps-314-vs-356-yoy
Artelo Biosciences FY23 EPS $(3.14) Vs $(3...
03/25/2024 12:20:41

Fiscal 2023 Year-End Financial ResultsCash and Investments: Cash and investments totalled $10.4 million as of December 31, 2023...

artelo-biosciences-has-been-granted-european-patent-number-ep3723752-titled-new-solid-forms-of-cannabidiol-and-uses-thereof-for-various-medical-treatments
Artelo Biosciences Has Been Granted Europe...
03/20/2024 16:06:17

https://register.epo.org/application?number=EP18887462 

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
03/06/2024 21:31:05

artelo-biosciences-announces-publication-of-new-peer-reviewed-pre-clinical-research-demonstrating-art2612s-effectiveness-in-treating-and-preventing-oxaliplatin-induced-peripheral-neuropathy
Artelo Biosciences Announces Publication O...
01/23/2024 13:32:31

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways...

artelo-biosciences-announces-selection-of-worldwide-clinical-trials-as-clinical-research-organization-to-support-first-in-human-study-of-art2612
Artelo Biosciences Announces Selection Of ...
01/08/2024 13:47:31

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION